Moderna coronavirus vaccine begins phase 3 trial with 30,000 participants
The Moderna vaccine phase three trial is underway with 30,000 people taking part. Half will receive the vaccine and the rest will get a placebo. Meg Oliver has the details.
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.